Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ZOVIRAX 5 %

ACYCLOVIR : 5 % · DIN 02039524 · BAUSCH HEALTH, CANADA INC.

Health Canada status: MARKETED

What is ZOVIRAX?

ZOVIRAX 5 % contains ACYCLOVIR : 5 %. It is listed in the Health Canada Drug Product Database under DIN 02039524, held by BAUSCH HEALTH, CANADA INC., supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 22-Dec-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is ZOVIRAX used for?

Zovirax (acyclovir 5%) cream is indicated for the topical management of initial episodes of genital herpes simplex infections. Zovirax (acyclovir 5%) ointment is for the management of initial episodes of genital herpes simplex infections. It is also indicated in the management of non-life-threatening cutaneous herpes simplex virus infections in immunocompromised patients.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

What else is ZOVIRAX called?

The same molecule, ACICLOVIR, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
ACICLOVIRLatinBrazil
CICLOVIRALLatinMorocco
ANTIVIRAXLatinBrazil
HERVIRAXLatinBrazil
ACICLOVIR NORIDEMLatinCzechia
ACIVIRLatinMorocco
HPMIXLatinBrazil
ACICLOVIR OLIKLALatinCzechia
Aciclovir SandozLatinAustralia
APO-AciclovirLatinAustralia
ARX-ACICLOVIRLatinAustralia
REVOCIRLatinMorocco
XOROXLatinAustralia, Czechia
ZIRVINLatinCzechia
ACICLOVIR ACCORDLatinCzechia

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Product details and regulatory record

DIN02039524
Brand nameZOVIRAX
Generic / active ingredientACYCLOVIR : 5 %
ManufacturerBAUSCH HEALTH, CANADA INC.
Strength5 %
Dosage formCREAM
Route of administrationTOPICAL
SchedulePrescription
ATC codeD06BB03 ACICLOVIR
AHFS class84:04.06
BiosimilarNo
Health Canada statusMARKETED
Status date22-Dec-2020
Original market date1993-12-31 00:00:00

How is this product identified?

Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.

DIN (8-digit, as used in Nexara ordering)02039524
DIN (unpadded, as printed on some documents)2039524
Brand nameZOVIRAX
Active ingredient / INNACYCLOVIR : 5 %
ATC codeD06BB03
ATC anatomical main groupD — Dermatologicals
ATC therapeutic subgroupD06
AHFS class84:04.06
Health Canada schedulePrescription
Biosimilar biologicNo
Market authorization holderBAUSCH HEALTH, CANADA INC.

Health Canada approved product monograph (PDF)

How is it administered?

Apply liberally to affected area 4 to 6 times daily for up to 10 days. Use a finger cot or rubber glove to apply. Initiate therapy as early as possible following onset of signs/symptoms.

Included because it drives pack selection and wastage. Consult the monograph.

How is it stored and handled?

Cream: Store between 15°C and 25°C and kept dry. Ointment: Store between 15°C to 25°C and kept dry.

How is it supplied?

Cream: tubes of 5g. Ointment: tubes of 4g and 30g.

Which pack is which?

Strength on the label5 %
Dosage formCREAM
RouteTOPICAL
Packaging as described in the monographCream: tubes of 5g. Ointment: tubes of 4g and 30g.
StorageCream: Store between 15°C and 25°C and kept dry. Ointment: Store between 15°C to 25°C and kept dry.

One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Confirm the pack and get a price

Contraindications

Hypersensitivity or chemical intolerance to acyclovir, valacyclovir, or any components of the formulation (e.g., propylene glycol, polyethylene glycol).

Warnings and precautions

For topical use only; do not use in the eye or on mucous membranes (mouth or vagina). Does not prevent transmission to others. Not for prevention of recurrence.

What can be used instead?

Other Canadian products sharing ATC code D06BB03 ACICLOVIR. 4 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
APO-ACYCLOVIR OINTMENT5 %OINTMENTAPOTEX INCMARKETEDDIN 02477130
TARO-ACYCLOVIR5 %OINTMENTTARO PHARMACEUTICALS INCMARKETEDDIN 02522306
ZOVIRAX5 %OINTMENTBAUSCH HEALTH, CANADA INC.MARKETEDDIN 00569771
MINT-ACYCLOVIR OINTMENT5 %OINTMENTMINT PHARMACEUTICALS INCAPPROVEDDIN 02560437

Who else supplies ACICLOVIR worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. ACICLOVIR appears in 6029 registered pack listings across 7 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How much does ACICLOVIR cost around the world?

ACICLOVIR is listed on 14 national price registers Nexara tracks, across 336 pack listings published on 14 different price bases. What each country publishes is set out below.

MarketWhat that country publishesBrands listedPack listingsAs of
Brazilpreco fabrica (ex-factory ceiling)119502 Sep 2026
Italyprezzo al pubblico (classe A)154302 Sep 2026
MoroccoPPV (public price)72705 Sep 2026
SpainPVP con IVA (public price)262605 Sep 2026
Romaniamax producer price202503 Sep 2026
Czechiamax producer price (ex-factory)82203 Sep 2026
South Africasingle exit price181901 Sep 2026
United Arab Emiratespublic141631 Aug 2026
Australiaex-manufacturer71608 Sep 2026
AustriaKVP (Kassenverkaufspreis)151503 Sep 2026
United Kingdomhospital131331 Aug 2026
Greeceproducer price (ex-factory)101003 Sep 2026
Luxembourgreimbursement6605 Sep 2026
Belgiumpublic2201 Sep 2026
Italyex-factory (classe H)1102 Sep 2026

Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.

Ask Nexara for a landed Canadian price

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ZOVIRAX

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02039524. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.